Federal Register Notice: FDA is withdrawing approval of a Wyeth Pharmaceuticals’ NDA for Mylotarg (gemtuzumab ozogamicin) for injection. Wyeth has voluntarily requested that approval of this application be withdrawn, thereby waiving its opportunity for a hearing. To view this notice, click here.
